AGEN ▲ +1.1% - Agenus Inc. $AGEN Agenus to Present BOT+BAL Long-Term Survival Data and Translational Research With agenT-797 in Colorectal Cancer at SITC 2026 02-OCT-2026 09:02 AM ET